PDK1 and central nervous system cancer: Additionally, PDK1 is validated to be a target gene of miR-454 in glioma, and miR-454 overexpression significantly inhibits PDK1 expression, thereby suppressing cell growth and blocking the cell cycle in G0/G1 phase [35].